ArticleFrontiers in medicine2025
Comparative astigmatic accuracy and optical quality of SMILE, FS-LASIK, and TICL in mild-to-moderate myopia with ≥1.00 D astigmatism.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Femtosecond laser-assisted LASIK in the SMILE era: a mini review of patient-centered procedure selection.Frontiers in medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Considering the unresolved trade-offs between astigmatic precision and optical quality in mild-to-moderate myopia with ≥1.0 D astigmatism, this study compares astigmatic correction accuracy and higher-order aberrations (HOAs) among three methods: small incision lenticule extraction (SMILE), femtosecond laser-assisted Methods: This retrospective, non-randomized comparative study enrolled 159 eyes of 159 patients. Study participants underwent either SMILE ( Results: At 3 months, the residual cylinder value was significantly lower in the SMILE (-0.21 ± 0.25 D) and FS-LASIK (-0.30 ± 0.23 D) groups than in the TICL group (-0.50 ± 0.26 D) ( Conclusion: SMILE, FS-LASIK, and TICL implantation are all effective for correcting mild-to-moderate myopia with ≥1.0 D astigmatism. SMILE led to superior astigmatic correction accuracy compared with TICL and showed better astigmatic correction than FS-LASIK in this cohort. Meanwhile, TICL implantation induced significantly fewer HOAs than both SMILE and FS-LASIK, resulting in superior postoperative optical quality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.